Dosing of PD-1 and PD-L1 inhibitors: Cost saving initiatives for significantly decreasing associated expenditure
Author:
Affiliation:
1. Cancer Care Services, Toowoomba Hospital, Toowoomba, Australia
2. Rural Clinical School, Faculty of Medicine, The University of Queensland, Toowoomba, Australia
Publisher
SAGE Publications
Subject
Pharmacology (medical),Oncology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1078155220974077
Reference25 articles.
1. Immuno-oncology drug development goes global
2. Setting the Dose of Checkpoint Inhibitors: The Role of Clinical Pharmacology
3. Product review on the Anti-PD-L1 antibody atezolizumab
4. Assessment of nivolumab benefit–risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors
5. Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Virtual clinical trials via a QSP immuno-oncology model to simulate the response to a conditionally activated PD-L1 targeting antibody in NSCLC;Journal of Pharmacokinetics and Pharmacodynamics;2024-06-10
2. Eliciting the antitumor immune response with a conditionally activated PD‐L1 targeting antibody analyzed with a quantitative systems pharmacology model;CPT: Pharmacometrics & Systems Pharmacology;2023-12-07
3. Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer;Journal of Oncology Pharmacy Practice;2023-11-21
4. Testing alternative schedules of adjuvant immune checkpoint blockers – The need for well-designed clinical trials;European Journal of Cancer;2023-01
5. Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab;Journal of Oncology Pharmacy Practice;2022-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3